FOXO3 and neoplasm: These findings indicate a potential contribution of NO-ERK-FOXO3 signaling in pancreatic tumorigenesis in KPC mice, and the reduced phosphorylation of FOXO, in the context of NOS2-deficiency, may contribute to the reduced tumor severity and increased survival in NKPC as compared with KPC mice.